TITLE

Liver enzyme alteration: a guide for clinicians

AUTHOR(S)
Giannini, Edoardo G.; Testa, Roberto; Savarino, Vincenzo
PUB. DATE
February 2005
SOURCE
CMAJ: Canadian Medical Association Journal;2/1/2005, Vol. 172 Issue 3, p367
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
ISOLATED ALTERATIONS OF BIOCHEMICAL MARKERS OF LIVER DAMAGE in a seemingly healthy patient can present a challenge for the clinician. In this review we provide a guide to interpreting alterations to liver enzyme levels. The functional anatomy of the liver and pathophysiology of liver enzyme alteration are briefly reviewed. Using a schematic approach that classifies enzyme alterations as predominantly hepatocellular or predominantly cholestatic, we review abnormal enzymatic activity within the 2 subgroups, the most common causes of enzyme alteration and suggested initial investigations.
ACCESSION #
15784111

 

Related Articles

  • Evaluation of Tumor Markers Panel in Detection of HCC in HCV Egyptian Patients and its Correlation with AFP. Gameel, M.; El Assaly, N.; Medany, H.; El-Ashry, N.; Mostafa, I.; El Raof, E. Abd; El-Rasky, M. // Research Journal of Medicine & Medical Sciences;2009, Vol. 4 Issue 2, p402 

    Objective: was to assay A FP the usual recommended parameter in combination with serum α-Lfucosidase, aflatoxin, Fas, Fas ligand, iron and ferritin as a non-invasive parameters helping in early detection of HCC in Egyptian chronic liver disease patients. As hepatocellular carcinoma (HCC) is...

  • Circulating AIM as an Indicator of Liver Damage and Hepatocellular Carcinoma in Humans. Yamazaki, Tomoko; Mori, Mayumi; Arai, Satoko; Tateishi, Ryosuke; Abe, Masanori; Ban, Mihoko; Nishijima, Akemi; Maeda, Maki; Asano, Takeharu; Kai, Toshihiro; Izumino, Kiyohiro; Takahashi, Jun; Aoyama, Kayo; Harada, Sei; Takebayashi, Toru; Gunji, Toshiaki; Ohnishi, Shin; Seto, Shinji; Yoshida, Yukio; Hiasa, Yoichi // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    Background: Hepatocellular carcinoma (HCC), the fifth most common cancer type and the third highest cause of cancer death worldwide, develops in different types of liver injuries, and is mostly associated with cirrhosis. However, non-alcoholic fatty liver disease often causes HCC with less...

  • Perspectives on a combined test of multi serum biomarkers in China: Towards screening for and diagnosing hepatocellular carcinoma at an earlier stage. Keming Zhang; Peipei Song; Jianjun Gao; Gaohua Li; Xin Zhao; Shaogeng Zhang // Drug Discoveries & Therapeutics;Jun2014, Vol. 8 Issue 3, p102 

    China has 50% of the worldwide hepatocellular carcinoma (HCC) cases, and the HBV-related cases accounts for approximately 85%. Over the past few decades, although a series of standardized management methods for HCC has been implemented in China, most HCC patient in China still suffered from...

  • The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma. Kanmura, Shuji; Uto, Hirofumi; Sato, Yuko; Kumagai, Koutarou; Sasaki, Fumisato; Moriuchi, Akihiro; Oketani, Makoto; Ido, Akio; Nagata, Kenji; Hayashi, Katsuhiro; Stuver, Sherri O.; Tsubouchi, Hirohito // Journal of Gastroenterology;Apr2010, Vol. 45 Issue 4, p459 

    Hepatocellular carcinoma (HCC) has a high mortality rate, and early detection of HCC improves patient survival. However, the molecular diagnostic markers for early HCC have not been fully elucidated. The aim of this study was to identify novel diagnostic markers for HCC. Serum protein profiles...

  • Keap1 eye on the target: chemoprevention of liver cancer. Yates, Melinda Sue; Kensler, Thomas Wells // Acta Pharmacologica Sinica;Sep2007, Vol. 28 Issue 9, p1331 

    Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, causing nearly 600 000 deaths each year. Increased risk of HCC due to chronic infection with hepatitis B virus (HBV) and exposure to dietary aflatoxins is responsible for many of these deaths. Prevention strategies...

  • Lithocholic acid as a biomarker of intrahepatic cholestasis of pregnancy during ursodeoxycholic acid treatment. Lucangioli, Silvia E.; Castaño, Gustavo; Contin, Mario D.; Tripodi, Valeria P. // Annals of Clinical Biochemistry;Jan2009, Vol. 46 Issue 1, p44 

    Background: The diagnosis and treatment of intrahepatic cholestasis of pregnancy (ICP) has important implications on fetal health. The biochemical parameter commonly used in the diagnosis of ICP is the determination of the concentration of total serum bile acids (TSBA). However, bile acid...

  • Association of laboratory parameters with viral factors in patients with hepatitis C.  // Virology Journal;2011, Vol. 8 Issue 1, p361 

    The article focuses on a cross-sectional and observational study of patients infected with hepatitis C virus (HCV). HCV RNA positive patients were chosen in the study who were divided into three cohorts to validate the data. The study found that all genotypes except 4a have no association with...

  • Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest). Munteanu, Mona; Messous, Djamila; Thabut, Dominique; Imbert-Bismut, Françoise; Jouys, Matheiu; Massard, Julien; Piton, Annie; Bonyhay, Luminita; Ratziu, Vlad; Hainque, Bernard; Poynard, Thierry // Comparative Hepatology;2004, Vol. 3, p1 

    Background: Biochemical marker combinations, including α2-macroglobulin, haptoglobin, apolipoprotein A1, γ-glutamyl transpeptidase, and total bilirubin (all part of FibroTest) plus alanine aminotransferase (all part of ActiTest), are being developed as alternatives to liver biopsy in...

  • AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease. Beale, Gary; Chattopadhyay, Dipankar; Gray, Joe; Stewart, Stephen; Hudson, Mark; Day, Christopher; Trerotoli, Paolo; Giannelli, Gianluigi; Manas, Derek; Reeves, Helen // BMC Cancer;2008, Vol. 8, Special section p1 

    Background: The incidence and mortality of hepatocellular cancer (HCC) complicating alcoholic and non-alcoholic fatty liver diseases (ALD and NAFLD) is rising in western societies. Despite knowing the at risk populations for HCC development, the lack of sensitive and specific means of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics